Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasan Sulaeman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Emerging Infectious Diseases|February 24, 2022
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related ApplicationsMars Stone, Eduard Grebe, Hasan Sulaeman, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
Cryptic diversity of a widespread global pathogen reveals expanded threats to amphibian conservationAllison Q Byrne, Vance T Vredenburg, An Martel, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Evolutionary Ecology|June 9, 2020
CpG-creating mutations are costly in many human virusesVictoria R Caudill, Sarina Qin, Ryan Winstead, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Emerging Infectious Diseases|February 24, 2022
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related ApplicationsMars Stone, Eduard Grebe, Hasan Sulaeman, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
Cryptic diversity of a widespread global pathogen reveals expanded threats to amphibian conservationAllison Q Byrne, Vance T Vredenburg, An Martel, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Evolutionary Ecology|June 9, 2020
CpG-creating mutations are costly in many human virusesVictoria R Caudill, Sarina Qin, Ryan Winstead, et al.
Pageof 2